Effect of Magnesium Supplement on Pregnancy Outcomes: A Randomized Control Trial
Zarean E, Tarjan A
Advanced biomedical research · 36 citations
How it was studied
- Design
- Randomized controlled trial (classified by our AI screen)
- Studied in
- People
- Main outcome
- Clinical events such as disease or death
Who paid for it
- Funding
- Independent funding
Based on full-text disclosure statement.
Publication
- Published
- 2017-01-01 · Adv Biomed Res · vol. 6 · issue 1 · p. 109
- Publisher
- Medknow
- Cited
- 69 citations · more than 95% of similar papers · 4.2× the field average
- Impact
- Top 10% most cited in its field
- References
- 45 works
- Access
- Open access (journal) · CC-BY-NC-SA
- Research areas
- Preterm Birth and Chorioamnionitis · Magnesium in Health and Disease · Pregnancy and preeclampsia studies
- Keywords
- Pregnancy, Medicine, Gestational diabetes, Preeclampsia, Randomized controlled trial, Hypomagnesemia, Apgar score, Obstetrics, Body mass index, Gestational age, Gestation, Internal medicine, Magnesium
2 authors
From IR
- Elaheh ZareanIsfahan University of Medical Sciences; Alzahra Medical and Education Center
- Amal Tarjan · correspondingIsfahan University of Medical Sciences; Alzahra Medical and Education Center
Abstract
Background
Magnesium (Mg) is an essential mineral required to regulate body temperature, nucleic acid, and protein synthesis with an important role in maintaining nerve and muscle cell electrical potentials. It may reduce fetal growth restriction and preeclampsia as well as increase birth weight. This study aimed to assess the effects of consuming Mg supplementation during pregnancy on pregnancy outcomes.
Materials and methods
This is a randomized controlled trial with three sixty populated groups of pregnant women. Participants were randomized to treatment or control groups through random table numbers. Participants with Mg serum levels more than 1.9 mg/dl considered as control group A randomly. They just received one multimineral tablet once a day until the end of pregnancy participants with hypomagnesemia consider as Group B and C. Participants in Group B received one multimineral tablet daily until the end of pregnancy. Participants in Group C received 200 mg effervescent Mg tablet from Vitafit Company once daily for 1 month, and also they consumed one multimineral tablet from Alhavi Company, which contains 100 mg Mg, once a day until the end of pregnancy. Intrauterine growth retardation, preterm labor, maternal body mass index, neonatal weight, pregnancy-induced hypertension, preeclampsia, gestational diabetes mellitus, cramps of the leg Apgar score were compared between three groups.
Results
In all pregnancy outcomes, Group C that received effervescent Mg tablet plus multimineral showed a better result than other groups, and frequency of complications of pregnancy was fewer than the other two groups and showed a significant difference.
Conclusion
Mg supplement during pregnancy likely decrease probability occurrence of many complications of pregnancy.
Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY-NC-SA).
Community trust
Loading…
How much do you trust this study's findings?
Comments
Sign in to rate, comment on or flag this study.Sign inSomething wrong here?
Flag this study if its information, labels or funding look wrong. An editor reviews every flag.
Sign in to rate, comment on or flag this study.Sign inEducational information about published research. Not medical advice, and not a recommendation to start or stop anything.